These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39226788)

  • 1. Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study.
    Botton J; Bertrand M; Jabagi MJ; Duranteau L; Bouillon K; Drouin J; Semenzato L; Le Vu S; Weill A; Zureik M; Dray-Spira R
    Vaccine; 2024 Oct; 42(24):126252. PubMed ID: 39226788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study.
    Ljung R; Xu Y; Sundström A; Leach S; Hallberg E; Bygdell M; Larsson M; Arthurson V; Gisslén M; Gedeborg R; Nyberg F
    BMJ; 2023 May; 381():e074778. PubMed ID: 37137493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study.
    Turpin A; Semenzato L; Le Vu S; Jabagi MJ; Bouillon K; Drouin J; Bertrand M; Kanagaratnam L; Weill A; Dray-Spira R; Zureik M; Botton J
    J Infect Public Health; 2024 Jul; 17(7):102450. PubMed ID: 38823086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics.
    Wang S; Mortazavi J; Hart JE; Hankins JA; Katuska LM; Farland LV; Gaskins AJ; Wang YX; Tamimi RM; Terry KL; Rich-Edwards JW; Missmer SA; Chavarro JE
    Am J Obstet Gynecol; 2022 Nov; 227(5):739.e1-739.e11. PubMed ID: 35841938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination.
    Trogstad L; Laake I; Robertson AH; Mjaaland S; Caspersen IH; Juvet LK; Magnus P; Blix K; Feiring B
    Vaccine; 2023 Aug; 41(36):5271-5282. PubMed ID: 37451876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
    Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
    Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal uterine bleeding diagnoses and care following COVID-19 vaccination.
    Brooks N; Irving SA; Kauffman TL; Vesco KK; Slaughter M; Smith N; Tepper NK; Olson CK; Weintraub ES; Naleway AL;
    Am J Obstet Gynecol; 2024 May; 230(5):540.e1-540.e13. PubMed ID: 38219855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
    Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of and risk factors for self-reported menstrual changes following COVID-19 vaccination: a Danish cohort study.
    Bisgaard Jensen C; Bech BH; Hansen SN; Rask CU; Fink P; Nielsen H; Meinertz Dantoft T; Thysen SM; Rytter D
    Hum Reprod; 2023 Sep; 38(9):1825-1834. PubMed ID: 37437904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-age Women: A Multi-centric Observational Study.
    Kumar N; Gangane N; Mohapatra I; Rukadikar C; Sharmila V; Pushpalatha K; Eerike M; Santhoshi G; Samantaray SR; Seth S; Trigunait P; Reddy NJ; Patel S; Rani S; Mishra R; Negi K
    Curr Drug Res Rev; 2024; 16(2):237-248. PubMed ID: 37291775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual abnormalities after COVID-19 vaccination in the Netherlands: A description of spontaneous and longitudinal patient-reported data.
    Duijster JW; Schoep ME; Nieboer TE; Jajou R; Kant A; van Hunsel F
    Br J Clin Pharmacol; 2023 Oct; 89(10):3126-3138. PubMed ID: 37222170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
    Laniece Delaunay C; Mazagatos C; Martínez-Baz I; Túri G; Goerlitz L; Domegan L; Meijer A; Rodrigues AP; Sève N; Ilic M; Latorre-Margalef N; Lazar M; Maurel M; Melo A; Andreu Ivorra B; Casado I; Horváth JK; Buda S; Bennett C; de Lange M; Guiomar R; Enouf V; Mlinaric I; Samuelsson Hagey T; Dinu S; Rumayor M; Castilla J; Oroszi B; Dürrwald R; O'Donnell J; Hooiveld M; Gomez V; Falchi A; Kurecic Filipovic S; Dillner L; Popescu R; Bacci S; Kaczmarek M; Kissling E;
    JAMA Netw Open; 2024 Jul; 7(7):e2419258. PubMed ID: 38949812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis.
    Martínez-Zamora MÁ; Feixas G; Gracia M; Rius M; Quintas L; de Guirior C; Carmona F
    Womens Health (Lond); 2023; 19():17455057231176751. PubMed ID: 37282979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.